Methylene Blue: A Potential Treatment for Brain Diseases and Cancer

https://pubmed.ncbi.nlm.nih.gov/26603930/

Methylene blue (MB) is a medication that's been used for over a century to treat various health issues. Recent studies have found that MB can help improve the way our cells produce energy, especially in the mitochondria, which are the powerhouses of our cells. This improvement in energy production can be beneficial for treating brain diseases like Alzheimer's and Parkinson's, as well as certain types of cancer. MB works by enhancing mitochondrial function, reducing stress in cells, and promoting better overall cell performance.

In the context of cancer, MB has shown promise in slowing down tumour growth. It appears to counteract a process that tumours use to grow rapidly by promoting a more normal energy production pathway in cells. This shift can lead to reduced cancer cell proliferation and may offer a new approach to cancer treatment. These findings suggest that MB could be a valuable tool for improving brain health and developing new therapies for cancer.